LMRI
Lumexa Imaging Holdings, Inc.
Key Financials
Operating Income
$42.5M
N/A
Revenue
$516.7M
N/A
Net Income
$4.5M
N/A
EPS (Diluted)
$0.05
N/A
Shareholders' Equity
$615.1M
N/A
Total Liabilities
$1.2B
N/A
Total Assets
$1.8B
N/A
Cash & Equivalents
$69.7M
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G | 8/14/2026 | View on SEC |
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 8/12/2026 | View on SEC |
| 8-K | 6/30/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LMRI |
| Company Name | Lumexa Imaging Holdings, Inc. |
| CIK | 2071288 |
| Sector | Services-Medical Laboratories |
| Industry | Non-accelerated filer Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 704-334-7830 |